IDAHO FALLS, Idaho, Nov. 29, 2018 /PRNewswire/ -- Divinia Water, Inc. and the National University of Natural Medicine announce a revolutionary study based on DIVINIA Water's effect on particular human health problems, approved by NUNM's Institutional Review Board.
The clinical trial will test the effects of DIVINIA Water on Chronic Kidney Disease, liver diseases and Hepatitis. The study was formally approved by the IRB to enter the next phase of testing, which should begin in 2019 with trials conducted by NUNM at its Helfgott Research Institute in Portland, Oregon for a period up to one year.
"To get a fully accredited university on board for this study is extraordinary," said Steven Sedlmayr, CEO of Divinia Water. "We can do a medically approved clinical test on DIVINIA Water's potential benefits for specific patients. This is the first of its kind, to my knowledge, it's never been done before."
The protocol for the study, developed by NUNM and approved by the IRB, tests DIVINIA Water's effects compared to the results of drinking regular bottled water or even tap water.
The trial's results could show sufferers and the broad medical community there is a more natural and holistic approach to care for CKD, liver diseases and Hepatitis that compare to, or even exceed, the current standard of care.
The Center for Disease Control estimates over 30 million American adults have CKD. The kidneys balance electrolytes in the human body, maintaining the proper levels of salts. The liver and the kidneys are major organs, and provide for the body's filtration system, along with other critical functions.
According to the CDC, death rates from chronic liver disease increased 31 percent from 2000 to 2015. That's an increase of 20.1 per 100,000 to 26.4 among people aged 45-64.
The liver is the largest of the glandular organs. It features over 200 functions in the human body. To keep it healthy, or return it to a healthy state, is critical for patients to maintain health.
"This is not an evolutionary step, but rather, a revolutionary step," Sedlmayr said. "This trial can position DIVINIA Water as the leader in functional water for wellness reasons, as we will be the only company ever to provide a clinical study on the effects of drinking a particular water and its effects upon particular organs and diseases."
"Water is the battery of life," said Sedlmayr. "However, too much of our water supply is contaminated."
Since DIVINIA Water is a unique, ultra-purified water with distinct changes to its electro-magnetic particle properties, along with the depletion of heavy water particles (or Deuterium Depleted), this trial will apply only to DIVINIA Water, and no other waters.
"An IRB approval is a crucial step in the process of a clinical trial, and might be the largest barrier to overcome," Sedlmayr said. "Their approval allows us to use one of the most powerful tools in clinical research, the randomized controlled trial (RCT)."
An RCT allocates patients by random to receive one of multiple clinical interventions. One intervention is the standard of comparison, or control. Investigators study two or more interventions in a series of individuals who receive them in random order.
Preliminary results are expected in 2019.
About DIVINIA Water:
DIVINIA Water is a bottled water brand focused on offering uniquely pure, clean, functional, eco-friendly and hydrating water. DIVINIA's headquarters are in Idaho Falls, Idaho.
The National University of Natural Medicine established in 1956 is the oldest accredited naturopathic medical university in North America and a leader in natural medicine education and evidence-based research. www.nunm.edu
SOURCE Divinia Water